The worldwide increase in the prevalence of diabetes mellitus has raised the demand for
new therapeutic strategies targeting diabetic symptoms and its chronic complications …

Type 2 diabetes mellitus (T2DM) is mainly characterized by insulin resistance (IR) and
impaired insulin secretion. The chronic inflammatory process contributed to IR and could …

Type 1 diabetes mellitus (T1DM) is caused by the autoimmune targeting of pancreatic β-
cells, and, in the advanced stage, severe hypoinsulinemia due to islet destruction. In …

Obesity is a critical risk factor for the development of metabolic diseases, and its prevalence
is increasing worldwide. Stem cell‐based therapies have become a promising tool for …

Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged
cells, exerting anti‐inflammatory responses and producing immunoregulatory effects that …

Diabetes mellitus is a type of metabolic disease characterized by hyperglycemia, primarily
caused by defects in insulin secretion, insulin action, or both. Long-term chronic …

Adipose-derived mesenchymal stem cells (AD-MSCs) have been shown to ameliorate
hyperglycemia in diabetic animals and individuals. However, little is known about whether …

Type 2 diabetes mellitus (T2DM), which is characterized by the combination of relative
insulin deficiency and insulin resistance, cannot be reversed with existing therapeutic …

Diabetes mellitus (DM), a chronic disorder of carbohydrate metabolism, is characterized by
the unbridled hyperglycemia resulted from the impaired ability of the body to either produce …

Background aims Stem cell therapy (SCT) is now the up-coming therapeutic modality for
treatment of type 1 diabetes mellitus (T1DM). Methods Our study was a prospective, open …